Skip to Content

CNN – Health

FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease

By Jen Christensen, CNN (CNN) — The US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease. Donanemab, made by Indianapolis-based Eli Lilly, works by helping the body remove amyloid plaque buildup in the brain, a hallmark of Alzheimer’s disease. Lilly said it

Continue Reading

Some antidepressants contribute to weight gain more than others, study finds

By Sandee LaMotte, CNN (CNN) — Antidepressants can be lifesavers for many struggling with so many mental health diagnoses — anxiety, depression, obsessive-compulsive disorder, panic disorder, social phobias and post-traumatic stress disorder. Yet taking these mood-altering substances can lead to an unpleasant side effect for some — weight gain. While many people never add extra

Continue Reading

In new Alzheimer’s criteria, some see progress while others fear profit-driven ‘diagnostic creep’

By Brenda Goodman, CNN (CNN) — Editor’s note: “Dr. Sanjay Gupta Reports: The Last Alzheimer’s Patient” airs at 8 p.m. ET Sunday, July 7, on CNN. With another pricey Alzheimer’s disease treatment expected to receive an approval decision soon, the nonprofit Alzheimer’s Association has published the final version of its new diagnostic criteria for the disease.

Continue Reading